What the finding is, how it is assessed, which treatments address it in London, what will not work, how long results take and what moves the cost.
Facial fat compartments shrink and slide, the bone underneath resorbs at the orbit and the jaw, and the retaining ligaments relax. The face reads as tired before it reads as lined. Structural filler restores projection where it was lost. Adding volume where nothing was lost produces the heavy, wide appearance that is instantly recognisable and never asked for.
Treatments that address this
| Presents as | A flattened cheek, hollowing at the temple and under the eye, a heavier nasolabial fold, loss of definition along the jaw |
|---|---|
| Underlying cause | Fat compartment atrophy and descent, bone resorption, ligament laxity, cumulative ultraviolet exposure, weight change, smoking |
| Assessed by | The face at rest and in animation, in consistent light, compartment by compartment rather than as a single surface |
| Treatments that apply | Cheek filler, dermal fillers placed at depth, jawline filler, and bio-remodelling where the envelope is also poor |
| Treatments that do not | Anti-wrinkle injections, which quieten muscle and replace nothing; any topical preparation, which cannot restore fat or bone |
| Time to a settled result | Two to four weeks for filler placed at depth, longer where several compartments are staged in sequence |
The mid face is not a single cushion that deflates evenly. It is a set of discrete fat compartments separated by septa, resting on bone and anchored by retaining ligaments. Those compartments do not age at the same rate. The deep medial cheek fat and the fat of the temple lose volume early, while the superficial compartments above them hold their volume longer and, as support beneath them fails, migrate downward.
This is why the appearance is so often described as descent rather than emptiness. The nasolabial fold deepens because tissue that used to sit higher is now resting on it. The jaw loses its clean margin for the same reason. Treating either of those directly, without restoring what supported them, produces a heavier face rather than a rested one.
The skeleton changes in parallel. The orbital aperture widens with age, particularly at its inferolateral rim. The mandibular angle becomes more obtuse and the chin projects less. Skin, meanwhile, loses collagen and elastin, so it no longer retracts over a smaller underlying volume. Four separate processes converge on one appearance, and only one of them is treated by volume.
The face does not simply deflate. It empties in some places, slides in others, and loses the frame it was hung on.
An assessment that only examines the fold you point to will treat the fold you point to. That is the most reliable route to a face that has had a great deal of product and still does not look rested. In this condition the finding is almost never where the complaint is.
A thorough assessment works in layers and in compartments, and it works from the top of the face downward, because support at the temple and lateral cheek changes what the midface needs.
The output is a written plan naming the areas, the sequence and the reasoning. What the consultation covers sets out the full order.
Sequence matters more than product. Structure before contour, upper face before lower, and a deliberately conservative first treatment so that there is room to add at review rather than a need to dissolve.
Volume loss is routinely confused with two other findings that look identical in a bathroom mirror, and treating the wrong one is expensive in both money and appearance.
The first is laxity. Where the soft tissue has genuinely relaxed and there is excess, filling underneath makes the excess heavier. The face becomes wider and flatter and the result reads as puffiness. For significant laxity the treatment that matches the finding is surgical, and a clinic that will not say so is selling a compromise.
The second is shadow. A hollow may be a genuine volume deficit, or a skeletal ridge casting a shadow, or pigmentation, or a fluid pattern that changes through the day. Product placed into the wrong one of those produces a persistent puffy or bluish appearance that can last for years.
Ask whether the product proposed can be dissolved, whether hyaluronidase is held on the premises and in date, and who is competent to administer it out of hours. Hyaluronic acid fillers can be reversed. Several other categories cannot. That single difference should change what you agree to.
No topical preparation restores fat or bone, and no device marketed to the public reverses bone resorption. Improving skin quality changes how light falls on the face and is worth doing. It is not a substitute for structure.
Filler placed at depth is visible immediately, and the immediate appearance includes swelling. Judging on the day is the most reliable way to talk yourself into more product than the face needed. Swelling settles over the first fortnight and the tissue integrates across the same period, which is why review is at two weeks.
Longevity depends on gel, plane and area. Firm gels on bone in relatively static regions outlast soft gels in mobile tissue, and manufacturers commonly quote periods of a year or more for structural products. Metabolism, training load and the quantity placed all move that figure, so a range is more truthful than a number.
What matters more than the calendar is the state the face returns to. A conservatively planned face returns to its own baseline as product resorbs. A face treated repeatedly before the previous product had gone does not, because tissue has been stretched. That is the argument for treating less at a time and reviewing properly.
There is no price list on this site. Cost for this condition is driven almost entirely by how many compartments need addressing and how much product that takes, and neither can be known before a face has been assessed. London prices vary more widely than in any other part of the country, and the variation is not a reliable guide to quality in either direction.
A quotation materially below the rest usually differs on the last of those points. What treatment costs in London sets out the variables in full.
Restoring facial volume means placing material close to the vascular supply of the face. The complication that matters, vascular occlusion, is rare, and it is managed by preparation rather than by luck. That makes the practitioner question more consequential here than almost anywhere else.
London has the highest concentration of practitioners in the country and the widest range of standards. Dermal fillers are regulated as medical devices rather than medicines, so there is no prescription requirement and at present no general licence needed to inject them. Legislation enabling a licensing scheme in England exists but has not been brought into force.
The standards to expect from a clinic in London covers the full list.
Lift the tissue gently upward and outward in front of a mirror. If the appearance improves markedly with a small lift and there is visible excess when you release it, laxity is a significant part of the picture and filler alone will disappoint. If the face looks flat and shadowed rather than loose, volume is the more likely finding. That distinction belongs to the assessment, and knowing it exists changes the conversation.
It should not, and when it does it is a planning failure rather than an inevitable outcome. Volume placed where volume was lost restores proportion. Volume placed laterally in a face that has not lost it, or in quantities beyond what the tissue can accommodate, widens the face. Conservative first treatment and a two-week review are the safeguards.
It can be, and often it should not be. Staging lets each step be judged once swelling has settled and prevents small errors compounding across several areas. Where several compartments need attention, sequencing across a few months usually produces a better and ultimately cheaper result.
Not directly. Botulinum toxin type A reduces muscle contraction and replaces nothing. It has a supporting role where a muscle is actively pulling tissue downward, and it treats the movement lines that often accompany volume loss, but it is not a treatment for volume.
Regenerative injectables and bio-remodelling improve the quality and thickness of tissue in the treated area, which is a genuine effect and is not the same as restoring a lost fat compartment. Expect refinement rather than replacement, and expect months rather than weeks.
Treatment
The highest-leverage area on the face, and the easiest one to ruin by degrees.
Read
Treatment
A medical device, not a medicine. That single fact explains most of what is wrong with the market.
Read
Cost and value
Because advertising a prescription-only medicine to the public is prohibited under UK medicines law, and becau...
ReadTell us what you have noticed and how long it has been there. You will get a considered reply setting out which treatments apply to that finding, which do not, and what an assessment would need to establish first.
hello@aestheticlaunchlab.comPlease do not send clinical photographs or medical records by email. If something has gone wrong after a procedure, contact the practitioner who treated you, or NHS 111, rather than waiting for a reply here.